摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(n-甲氧基-n-甲基氨基)-2-氧代乙酸乙酯 | 139507-52-1

中文名称
2-(n-甲氧基-n-甲基氨基)-2-氧代乙酸乙酯
中文别名
2-(N-甲氧基-N-甲基氨基)-2-氧代乙酸乙酯
英文名称
ethyl 2-(methoxy(methyl)amino)-2-oxoacetate
英文别名
monoethoxyoxalic acid N-methoxy-N-methylamide;Ethyl 2-(N-Methoxy-N-methylamino)-2-oxoacetate;ethyl 2-[methoxy(methyl)amino]-2-oxoacetate
2-(n-甲氧基-n-甲基氨基)-2-氧代乙酸乙酯化学式
CAS
139507-52-1
化学式
C6H11NO4
mdl
——
分子量
161.158
InChiKey
PDTUTKXQNSJUKJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    180.5±23.0 °C(Predicted)
  • 密度:
    1.136±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.4
  • 重原子数:
    11
  • 可旋转键数:
    4
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.67
  • 拓扑面积:
    55.8
  • 氢给体数:
    0
  • 氢受体数:
    4

安全信息

  • 海关编码:
    2922509090
  • 包装等级:
    III
  • 危险类别:
    9
  • 危险性防范说明:
    P260,P264,P273,P301+P312,P305+P351+P338,P314
  • 危险品运输编号:
    3077
  • 危险性描述:
    H302,H319,H372,H410

SDS

SDS:87a049a83307cf255043c92382841b4f
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: Ethyl 2-(n-methoxy-n-methylamino)-2-oxoacetate
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: Ethyl 2-(n-methoxy-n-methylamino)-2-oxoacetate
CAS number: 139507-52-1

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, refrigerated.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C6H11NO4
Molecular weight: 161.2

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

  • 作为反应物:
    描述:
    5-乙炔苯并[1,3]间二氧杂环戊烯2-(n-甲氧基-n-甲基氨基)-2-氧代乙酸乙酯正丁基锂 作用下, 以 乙醚正己烷 为溶剂, 反应 2.5h, 以61%的产率得到ethyl 4-(benzo[d][1,3]dioxol-5-yl)-2-oxobut-3-ynoate
    参考文献:
    名称:
    阳离子手性PdII Lewis酸催化的硝基的不对称“乙炔” [3 + 2]环加成反应
    摘要:
    已经开发出对映体和硝酮的高度对映选择性的[3 + 2]环加成反应。很大体积的配体DTBM-SEGPHOS用于在线性乙炔双极性亲和体的远端反应中心进行有效的不对称诱导,并通过硝酮的配位防止Pd II催化剂失活。该反应在炔酮和硝酮中具有广泛的底物范围。
    DOI:
    10.1002/asia.201801016
  • 作为产物:
    描述:
    二甲羟胺盐酸盐草酰氯单乙酯三乙胺 作用下, 以 二氯甲烷 为溶剂, 反应 0.67h, 以53%的产率得到2-(n-甲氧基-n-甲基氨基)-2-氧代乙酸乙酯
    参考文献:
    名称:
    Synthesis of tetrasubstituted pyridines by the acid-catalysed Bohlmann–Rahtz reaction
    摘要:
    新近开发了一种简便的实验程序,用于在单一合成步骤中制备2,3,4,6-四取代吡啶。在此过程中,烯胺酯和炔酮通过迈克尔加成-环脱水反应在杂环化过程中催化,催化剂可为乙酸、Amberlyst 15离子交换树脂、锌(II)溴化物或镱(III)三氟甲磺酸盐。这种新型的单步布伦斯特德或路易斯酸催化Bohlmann-Rahtz反应,是一种直接、简单且高效的合成吡啶的方法,其反应温度较低,且无需分离反应中间体。
    DOI:
    10.1039/b203397f
点击查看最新优质反应信息

文献信息

  • Bismuth(<scp>iii</scp>)-catalyzed bis-cyclization of propargylic diol-esters: a unified approach for the synthesis of [5,5]- and [6,5]-oxaspirolactones
    作者:Digambar A. Kambale、Balasaheb R. Borade、Ravindar Kontham
    DOI:10.1039/d1ob00974e
    日期:——
    Herein we disclose an unprecedented intramolecular cascade strategy for the construction of α,β-unsaturated [5,5]- and [6,5]-oxaspirolactones that capitalizes on the π-electrophilic Lewis acid-catalyzed 5-exo-dig or 6-exo-dig mode of cyclization of propargylic diol esters, followed by dehydration and spirolactonization steps. Moreover, semi-protected substrates also delivered the respective oxaspirolactones
    在此,我们公开了一种前所未有的分子内级联策略,用于构建 α,β-不饱和 [5,5]- 和 [6,5]-氧杂螺内酯,该策略利用 π-亲电子路易斯酸催化的 5 -exo-dig或 6-炔丙基二醇酯环化的exo-dig模式,然后是脱水和螺内酯化步骤。此外,半保护底物还可以在最佳反应条件下以相同的容易程度和可观的收率递送各自的氧杂螺内酯。
  • Synthesis of tetrasubstituted pyridines by the acid-catalysed Bohlmann–Rahtz reaction
    作者:Mark C. Bagley、Christian Brace、James W. Dale、Maren Ohnesorge、Nathan G. Phillips、Xin Xiong、Justin Bower
    DOI:10.1039/b203397f
    日期:2002.7.11
    New facile experimental procedures for the preparation of 2,3,4,6-tetrasubstituted pyridines in a single synthetic step have been developed. Thus, an enamino ester and alkynone react by Michael addition–cyclodehydration in a heterocyclisation process that is catalysed by acetic acid, Amberlyst 15 ion exchange resin, zinc(II) bromide or ytterbium(III) triflate. The new one-step Brønsted or Lewis acid-catalysed Bohlmann–Rahtz reaction is a simple, direct and highly expedient method for the synthesis of pyridines that proceeds at a lower reaction temperature and avoids the need to isolate reaction intermediates.
    新近开发了一种简便的实验程序,用于在单一合成步骤中制备2,3,4,6-四取代吡啶。在此过程中,烯胺酯和炔酮通过迈克尔加成-环脱水反应在杂环化过程中催化,催化剂可为乙酸、Amberlyst 15离子交换树脂、锌(II)溴化物或镱(III)三氟甲磺酸盐。这种新型的单步布伦斯特德或路易斯酸催化Bohlmann-Rahtz反应,是一种直接、简单且高效的合成吡啶的方法,其反应温度较低,且无需分离反应中间体。
  • Novel pyrazinone derivatives
    申请人:——
    公开号:US20030203907A1
    公开(公告)日:2003-10-30
    The present invention relates to a compound of the general formula (I): 1 [Ar 1 is aryl fused to the adjacent pyrazinone ring at the 5th and 6th positions, etc., X is CO, etc., Y is CH, etc., Z is CH, etc., V is CH, etc., W n is —(CH 2 ) n — (n is zero to four), R 1 is H or optionally substituted lower alkyl, etc., R 2 is H, etc., R 3 and R 4 are the same or different and are each H, etc., R 5 and R 6 are the same or different and are each H, hydroxy, etc.] or a pharmaceutically acceptable salt or ester thereof; a pharmaceutical composition, an inhibitor of Cdk4 and/or Cdk6 or an anti-cancer agent, containing the same as an active ingredient; and a process for preparing them.
    本发明涉及一种通式(I)的化合物:1[Ar1是芳基,与相邻的吡唑酮环在第5和第6位置融合,等等,X是CO,等等,Y是CH,等等,Z是CH,等等,V是CH,等等,W是-(CH2)n-(n为零至四),R1是H或选择性取代的较低烷基,等等,R2是H,等等,R3和R4相同或不同,分别为H,等等,R5和R6相同或不同,分别为H,羟基,等等]或其药学上可接受的盐或酯;一种含有该化合物作为活性成分的制药组合物,Cdk4和/或Cdk6的抑制剂或抗癌剂;以及其制备方法。
  • [EN] FUSED, SPIROCYCLIC HETEROAROMATIC COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS<br/>[FR] COMPOSÉS HÉTÉROAROMATIQUES SPIROCYCLIQUES FUSIONNÉS POUR TRAITER LES INFECTIONS BACTÉRIENNES
    申请人:ASTRAZENECA AB
    公开号:WO2010043893A1
    公开(公告)日:2010-04-22
    The present invention relates to compounds of Formula (I); to pharmaceutically acceptable salts thereof, to methods of using them to treat bacterial infections, and to methods for their preparation.
    本发明涉及式(I)的化合物;其药学上可接受的盐;使用它们治疗细菌感染的方法;以及它们的制备方法。
  • Synthesis of 17-Deacetoxyl Chromodorolide B Based on a Gold-Catalyzed Alkoxycyclization Reaction
    作者:Chen Li、Tianfei Quan、Yibin Xue、Yuhui Cao、Si-Cong Chen、Tuoping Luo
    DOI:10.1021/acs.orglett.0c00247
    日期:2020.2.21
    A novel strategy to construct the highly oxidized 3-oxabicyclo[3.3.0]octane skeleton was developed via a gold-catalyzed cascade cyclization with 2,7-dioxabicyclo[3.2.0]hept-3-ene as the substrate. We utilized this methodology as the key reaction to synthesize 17-deacetoxyl chromodorolide B.
    通过以2,7-二氧杂双环[3.2.0]庚-3-烯为底物的金催化级联环化反应,提出了一种构建高氧化度的3-氧杂双环[3.3.0]辛烷骨架的新策略。我们将这种方法学用作合成17-脱乙酰氧基铬邻苯二酚B的关键反应。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物